A detailed history of Colonial Trust CO / Sc transactions in Incyte Corp stock. As of the latest transaction made, Colonial Trust CO / Sc holds 1,045 shares of INCY stock, worth $74,947. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,045
Previous 1,000 4.5%
Holding current value
$74,947
Previous $60,000 15.0%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$57.33 - $68.61 $2,579 - $3,087
45 Added 4.5%
1,045 $69,000
Q3 2023

Nov 13, 2023

BUY
$57.77 - $65.93 $28,885 - $32,965
500 Added 100.0%
1,000 $57,000
Q4 2022

Feb 14, 2023

BUY
$67.18 - $84.11 $33,590 - $42,055
500 New
500 $40,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Colonial Trust CO / Sc Portfolio

Follow Colonial Trust CO / Sc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust CO / Sc, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust CO / Sc with notifications on news.